UNRESECTABLE BLADDER UROTHELIAL CARCINOMA

Clinical trials for UNRESECTABLE BLADDER UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE BLADDER UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2

New cocktail of drugs takes on Hard-to-Treat bladder cancer

Disease control Not yet recruiting

This early-phase trial tests a combination of three drugs—enfortumab vedotin, pembrolizumab, and quemliclustat—in people with advanced bladder or urinary tract cancer that has spread or cannot be removed by surgery. The goal is to see if the combination is safe and effective. The…

Matched conditions: UNRESECTABLE BLADDER UROTHELIAL CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

UNRESECTABLE BLADDER UROTHELIAL CARCINOMA

Get alerted when new UNRESECTABLE BLADDER UROTHELIAL CARCINOMA trials appear

New cocktail of drugs takes on Hard-to-Treat bladder cancer